Insider Trading Alert - WETF, CI And PANW Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, March 11, 2014, 134 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $363.00 to $110,557,762.60.

Highlighted Stocks Traded by Insiders:

WisdomTree Investments (WETF) - FREE Research Report

Steinhardt Michael H who is Director at WisdomTree Investments sold 10,500 shares at $15.98 on March 11, 2014. Following this transaction, the Director owned 194,900 shares meaning that the stake was reduced by 5.11% with the 10,500-share transaction.

The shares most recently traded at $15.41, down $0.57, or 3.68% since the insider transaction. Historical insider transactions for WisdomTree Investments go as follows:

  • 4-Week # shares sold: 798,800
  • 12-Week # shares sold: 798,800
  • 24-Week # shares sold: 1.5 million

The average volume for WisdomTree Investments has been 2.9 million shares per day over the past 30 days. WisdomTree Investments has a market cap of $2.1 billion and is part of the financial sector and financial services industry. Shares are down 9.99% year-to-date as of the close of trading on Friday.

WisdomTree Investments, Inc., through its subsidiaries, operates as an exchange-traded funds (ETFs) sponsor and asset manager. It offers ETFs in equities, currency, fixed income, and alternatives asset classes. The company has a P/E ratio of 43.1. Currently there are 5 analysts that rate WisdomTree Investments a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WETF - FREE

TheStreet Quant Ratings rates WisdomTree Investments as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity, expanding profit margins, good cash flow from operations and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full WisdomTree Investments Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Cigna (CI) - FREE Research Report

Cordani David who is President & CEO at Cigna sold 100,800 shares at $79.21 on March 11, 2014. Following this transaction, the President & CEO owned 214,208 shares meaning that the stake was reduced by 32% with the 100,800-share transaction.

Manders Matthew G who is Pres. Regional & Operations at Cigna sold 18,136 shares at $79.34 on March 11, 2014. Following this transaction, the Pres. Regional & Operations owned 48,708 shares meaning that the stake was reduced by 27.13% with the 18,136-share transaction.

Sadler Jason D who is Pres. Global Individual HL&A at Cigna sold 9,911 shares at $78.92 on March 11, 2014. Following this transaction, the Pres. Global Individual HL&A owned 19,387 shares meaning that the stake was reduced by 33.83% with the 9,911-share transaction.

The shares most recently traded at $79.67, up $0.75, or 0.95% since the insider transaction. Historical insider transactions for Cigna go as follows:

  • 4-Week # shares sold: 514
  • 12-Week # shares sold: 514
  • 24-Week # shares sold: 6,695

The average volume for Cigna has been 1.8 million shares per day over the past 30 days. Cigna has a market cap of $21.6 billion and is part of the health care sector and health services industry. Shares are down 9.61% year-to-date as of the close of trading on Friday.

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. The stock currently has a dividend yield of 0.05%. The company has a P/E ratio of 15.3. Currently there are 8 analysts that rate Cigna a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CI - FREE

TheStreet Quant Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, largely solid financial position with reasonable debt levels by most measures and attractive valuation levels. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Cigna Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Palo Alto Networks (PANW) - FREE Research Report

Zuk Nir who is Cto at Palo Alto Networks sold 30,000 shares at $72.15 on March 11, 2014. Following this transaction, the Cto owned 2.9 million shares meaning that the stake was reduced by 1.01% with the 30,000-share transaction.

Chandna Asheem who is Director at Palo Alto Networks sold 26,250 shares at $77.09 on March 11, 2014. Following this transaction, the Director owned 247,401 shares meaning that the stake was reduced by 9.59% with the 26,250-share transaction.

The shares most recently traded at $78.26, up $1.17, or 1.5% since the insider transaction. Historical insider transactions for Palo Alto Networks go as follows:

  • 4-Week # shares sold: 50,000
  • 12-Week # shares sold: 246,814
  • 24-Week # shares sold: 349,475

The average volume for Palo Alto Networks has been 1.5 million shares per day over the past 30 days. Palo Alto Networks has a market cap of $5.1 billion and is part of the technology sector and computer hardware industry. Shares are up 20.85% year-to-date as of the close of trading on Friday.

Palo Alto Networks, Inc. offers a network security platform in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and Japan. The company's platform comprises Next-Generation Firewall that delivers application, user, and content visibility and control. Currently there are 11 analysts that rate Palo Alto Networks a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PANW - FREE

TheStreet Quant Ratings rates Palo Alto Networks as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full Palo Alto Networks Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Red Robin Slumps After Earnings Miss

Red Robin Slumps After Earnings Miss

Owner of Moviepass Sees Stock Plummet

Owner of Moviepass Sees Stock Plummet

Tiffany & Co. Sees a Strong Market in Asia

Tiffany & Co. Sees a Strong Market in Asia

Stocks Finish Higher After Release of Fed Minutes

Stocks Finish Higher After Release of Fed Minutes